Ascentage Pharma Group International Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -891.42B-940.01B-0.06B
Depreciation and Depletion 0.01B0.01B0.01B
Share-based Compensation 0.00B0.00B0.00B
Deferred Taxes 0.04B0.00B
Gains from Investment Securities 0.00B0.00B-0.00B
Non-cash Items -0.11B-0.10B-0.03B
Cash from Operations -0.10B-0.10B-0.02B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.00B0.00B0.00B
Depreciation & Amortization (CF) 0.01B0.00B0.00B
Change in Working Capital
Change in Receivables 0.00B-0.01B0.01B
Change in Inventory -0.00B-0.00B0.00B
Change in Account Payables 0.00B-0.00B0.00B
Other Working Capital Changes 0.00B0.09B-0.00B
Investing Activities
Capital Expenditures 0.03B0.01B0.00B
Sales of Property, Plant and Equipment 0.00B0.00B
Change in Intangibles 92.94B
Cash from Investing Activities -0.06B0.00B-0.05B
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances 0.11B0.13B0.07B
Change in Capital Stock
Shares Issued 0.00B0.07B0.07B
Misc.
Cash from Financing Activities 0.09B0.05B0.04B
Exchange Rate Effect 0.01B0.00B0.00B
Change in Cash -0.06B-0.05B-0.02B
Free Cash Flow -0.13B-0.11B-0.02B
Net Cash Flow -0.06B-0.05B-0.02B